Charlie Alvarez Appointed Alliance Family of Companies CEO

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Charlie Alvarez has been appointed the new Chief Executive Officer of Alliance Family of Companies, effective immediately. Charlie Alvarez brings more than 30 years of healthcare leadership experience and most recently served as Chief Executive Officer of DCI Health Technologies, Inc. He succeeds J. Randall Keene, who has served as interim CEO since June 2019. Keene will continue in his role as Chairman of the Alliance Board of Directors.

In making the announcement, Keene cited Alvarez’s extensive strategic experience and entrepreneurial track record. “Charlie is the right leader for this role, especially in the current environment,” said Keene. “After an extensive search, Charlie presented the perfect blend of industry experience and executive leadership to carry Alliance into the future. He also comes to the company with a strong belief in our core values, which are to provide the best solutions for the patient, provider, and payor. I am confident he will continue to drive Alliance’s focus on value-based healthcare delivery by providing accessible, high-quality neurodiagnostic services in the home, as these services shift out of the hospital setting.”

As Chief Executive Officer of Foxconn’s DCI Health Technology, Inc., a multinational health technology company, Alvarez was responsible for launching the company in the United States and driving its revenue and profitability growth. He joined DCI in 2017, when his previous company, Sotera Wireless Inc. was acquired by Foxconn. Alvarez had joined Sotera Wireless in 2014 as Senior Vice President of Sales and Marketing where he was responsible for growing sales and revenue. Sotera is a medical device company that specializes in body worn vital signs monitoring. Within two years, Alvarez grew the client base from seven hospitals to more than 55 and grew revenue by more than 75 percent, year-over-year.

Prior to Sotera, Alvarez was President and Co-Founder of Watermark Medical, a privately held sleep diagnostics and therapy company. Alvarez was President through the acquisition of SleepMed, Inc, in 2012, a company that also provided EEG services. At Watermark, Charlie pioneered the home sleep testing market and grew the company to become the market leader in five short years. Before co-founding Watermark, Alvarez held various leadership positions at CardioNet (Biotel), the world’s largest remote cardiac monitoring company and PSS/World Medical, now McKesson.

“I’m excited to be joining the Alliance team,” said Alvarez. “I believe Alliance has a great business model, high-quality services and a robust R&D pipeline to position it for high growth over the next several years. I look forward to applying my experience in the ever-changing medical marketplace to lead the company in the development of technology and services that help provide better healthcare solutions. Alliance is poised for hyper-growth as we prepare for the upturn in business as this crisis starts to wane.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.